Oscar Health Q2 Earnings Call Highlights

1 hour ago 2

MarketBeat

Sat, August 8, 2026 astatine 6:03 PM CDT 6 min read

Key Points

  • 5 Small Cap Stocks With Explosive Upside Potential

Oscar Health (NYSE:OSCR) reported grounds profitability for the archetypal fractional of 2026 and raised its full-year operating outlook, citing rank growth, disciplined pricing, favorable utilization trends and little administrative disbursal ratios.

Chief Executive Officer Mark Bertolini said the institution generated $1.1 cardinal successful net from operations and $1 cardinal successful nett income during the archetypal six months of the year. In the 2nd quarter, gross roseate 70% twelvemonth implicit twelvemonth to $4.9 billion, portion the aesculapian nonaccomplishment ratio, oregon MLR, improved by astir 12 percent points to 79.2%.

→ Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is Falling

Second-quarter net from operations totaled $389 million, compared with a nonaccomplishment successful the prior-year period, portion nett income was $362 million. Adjusted EBITDA was $415 million. The institution ended the 4th with 2.96 cardinal effectuated members, up 46% from a twelvemonth earlier, driven by above-market unfastened enrollment maturation and retention.

Guidance Raised Following First-Half Performance

Chief Financial Officer Scott Blackley said Oscar raised its full-year 2026 earnings-from-operations forecast to betwixt $500 cardinal and $700 million, representing a $250 cardinal summation from its anterior outlook. The institution maintained its gross outlook of $18.7 cardinal to $19 billion.

  • Full-year MLR is present expected to beryllium 81.5% to 82.5%, a 90-basis-point betterment astatine the midpoint from anterior guidance.

  • The SG&A disbursal ratio is expected to beryllium 15.6% to 16.1%, an betterment of 20 ground points astatine the midpoint.

  • Adjusted EBITDA is inactive expected to beryllium astir $115 cardinal supra net from operations.

Read Entire Article